These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25191656)

  • 41. Differences in the mitochondrial microsatellite instability of Keratoacanthoma and cutaneous squamous cell carcinoma.
    Alam MR; Alsulimani A; Haque S; Jung HR; Lee JH; Jeon CH; Kim DK
    Cancer Genet; 2021 Aug; 256-257():115-121. PubMed ID: 34111657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A clinicopathological analysis of keratoacanthoma in eye].
    Kang Y; Zhang J; Wu Z
    Yan Ke Xue Bao; 1997 Dec; 13(4):217-8, 220. PubMed ID: 11326911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Keratoacanthoma and Keratoacanthoma-Like Squamous Cell Carcinoma: Similar Morphology but Different Pathogenesis.
    Watanabe IC; Magalhães RF; de Moraes AM; Stelini RF; Cintra GF; Metze K; Cintra ML
    Medicine (Baltimore); 2015 Jun; 94(23):e934. PubMed ID: 26061320
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential diagnosis of keratoacanthoma and squamous cell carcinoma of the epidermis by MIB-1 immunohistometry.
    Biesterfeld S; Josef J
    Anticancer Res; 2002; 22(5):3019-23. PubMed ID: 12530035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma.
    Pancevski G; Pepic S; Idoska S; Tofoski G; Nikolovska S
    Open Access Maced J Med Sci; 2018 Mar; 6(3):531-535. PubMed ID: 29610614
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Role of p16, p21, p27, p53 and Ki-67 Expression in the Differential Diagnosis of Cutaneous Squamous Cell Carcinomas and Keratoacanthomas: An Immunohistochemical Study.
    Bedir R; Güçer H; Şehitoğlu İ; Yurdakul C; Bağcı P; Üstüner P
    Balkan Med J; 2016 Mar; 33(2):121-7. PubMed ID: 27403379
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Keratoacanthoma (KA): An update and review.
    Kwiek B; Schwartz RA
    J Am Acad Dermatol; 2016 Jun; 74(6):1220-33. PubMed ID: 26853179
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estimation of the volume-weighted mean nuclear volume discriminates keratoacanthoma from squamous cell carcinoma.
    Binder M; Steiner A; Mossbacher U; Hunegnaw M; Pehamberger H; Wolff K
    Am J Dermatopathol; 1998 Oct; 20(5):453-8. PubMed ID: 9790104
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The nuclear factor kappa B p50 subunit and cortactin as markers to distinguish between keratoacanthoma and well-differentiated squamous cell carcinoma.
    Fujii M; Honma M; Takahashi H; Ishida-Yamamoto A; Iizuka H
    Clin Exp Dermatol; 2011 Oct; 36(7):788-92. PubMed ID: 21883393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IMP-3 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.
    Soddu S; Di Felice E; Cabras S; Castellanos ME; Atzori L; Faa G; Pilloni L
    Eur J Histochem; 2013 Feb; 57(1):e6. PubMed ID: 23549465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasmacytoid dendritic cells in keratoacanthoma and squamous cell carcinoma: A blinded study of CD123 as a diagnostic marker.
    Fraga GR; Chow P
    J Cutan Pathol; 2020 Jan; 47(1):17-21. PubMed ID: 31449667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression.
    Takeda H; Kondo S
    Am J Pathol; 2001 May; 158(5):1633-7. PubMed ID: 11337361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The first report of diagnosing of keratoacanthoma in Chinese Han patients using dermoscopy and reflectance confocal microscopy.
    Wang X; Wang Y; Wang H; Zheng L; Guo Z; Fan X; Gao M
    Skin Res Technol; 2021 May; 27(3):422-427. PubMed ID: 33098126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Invasive squamous cell carcinoma initially diagnosed as a giant keratoacanthoma.
    Goldenhersh MA; Olsen TG
    J Am Acad Dermatol; 1984 Feb; 10(2 Pt 2):372-8. PubMed ID: 6368620
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Keratoacanthoma: Update on the Debate.
    Nirenberg A; Steinman H; Dixon A
    Am J Dermatopathol; 2021 Apr; 43(4):305-307. PubMed ID: 33395044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Solitary keratoacanthoma: a self-healing proliferation that frequently becomes malignant.
    Sánchez Yus E; Simón P; Requena L; Ambrojo P; de Eusebio E
    Am J Dermatopathol; 2000 Aug; 22(4):305-10. PubMed ID: 10949454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pseudocarcinomatous hyperplasia mimicking squamous cell carcinoma in a case of CD56-positive cytotoxic T-cell lymphoma.
    Ginsberg D; Hill H; Wilson B; Plaza JA; Schieke SM
    J Cutan Pathol; 2015 Mar; 42(3):194-198. PubMed ID: 25370871
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
    Sakiz D; Turkmenoglu TT; Kabukcuoglu F
    Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Keratoacanthoma and squamous cell carcinoma: study of PCNA and Le(Y) expression.
    Tsuji T
    J Cutan Pathol; 1997 Aug; 24(7):409-15. PubMed ID: 9274958
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.